PSPN Protein — Persephin

PSPN Protein — Persephin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PSPN Protein — Persephin</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PSPN</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PSPN — Persephin</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PSPN" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Pspn Protein — Persephin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

PSPN Protein — Persephin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PSPN Protein — Persephin</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PSPN</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PSPN — Persephin</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PSPN" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Pspn Protein — Persephin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Persephin (PSPN) is a neurotrophic factor that plays critical roles in the development, maintenance, and protection of various neuronal populations throughout the nervous system. As a member of the glial cell line-derived neurotrophic factor (GDNF) family, persephin has attracted considerable research attention due to its potent neuroprotective properties and potential therapeutic applications in treating neurodegenerative disorders and peripheral neuropathies. The protein is encoded by the PSPN gene and is classified within the transforming growth factor-beta (TGF-β) superfamily, reflecting its evolutionary relationship to a diverse group of signaling molecules involved in cellular growth, differentiation, and survival.

Overview

Persephin is a neurotrophic factor encoded by the [PSPN gene](/genes/pspn). It belongs to the GDNF (glial cell line-derived neurotrophic factor) family within the TGF-beta superfamily. UniProt ID: [O60543](https://www.uniprot.org/uniprot/O60543).

The GDNF family comprises several structurally related neurotrophic factors, including GDNF, neurturin (NRTN), artemin (ARTN), and persephin. Each of these proteins shares a characteristic cysteine knot fold and signals through a conserved mechanism involving interaction with specific GPI-anchored co-receptors (GFRα proteins) and subsequent activation of the RET receptor tyrosine kinase. While persephin was discovered later than its family members, research has demonstrated its unique biological activities and therapeutic potential, particularly in the context of dopaminergic neuron survival and peripheral nervous system maintenance [1][2].[@j1998]

Structure

Protein Architecture

Persephin possesses the characteristic structural features shared among GDNF family members, which are essential for its biological activity and receptor interactions.

• Cysteine knot motif — three disulfide bonds forming a stable core
• Homodimer — functional form is a disulfide-linked dimer
• N-terminal signal peptide — enables secretion

The cysteine knot motif represents a defining structural feature of the GDNF family, characterized by six conserved cysteine residues that form three disulfide bonds in a specific arrangement. This structural fold provides exceptional stability to the protein, allowing it to resist proteolytic degradation and maintain biological activity in various physiological environments [3]. The homodimeric quaternary structure is essential for functional activity, as the dimeric form exhibits significantly higher neurotrophic potency compared to monomeric species. The N-terminal signal peptide facilitates proper folding and secretion through the secretory pathway, allowing persephin to be released from producing cells and exert its effects on target tissues [4].

Structural Similarity

• Closely related to GDNF, neurturin, and artemin
• Conserved fold within the TGF-beta family

The high degree of structural conservation among GDNF family members underlies their overlapping yet distinct biological activities. Crystallographic studies have revealed that persephin adopts the same overall fold as other family members, with minor variations in surface charge distribution and loop regions that contribute to receptor binding specificity [5]. This structural similarity explains why persephin can interact with multiple GFRα co-receptors, albeit with different affinities, and activate diverse signaling pathways in target cells.

Normal Function

Neurotrophic Support

Persephin promotes the survival and maintenance of various neuronal populations throughout the central and peripheral nervous systems. Its neurotrophic activities extend to multiple neuron types, making it a pleiotropic factor with broad physiological significance.

Persephin promotes the survival and maintenance of:

• Dopaminergic [neurons](/entities/neurons) (substantia nigra)
• Motor neurons (spinal cord)
• Peripheral sensory and autonomic neurons

In the central nervous system, persephin demonstrates particular potency in supporting dopaminergic neurons located in the substantia nigra pars compacta, which are the primary neuronal population lost in Parkinson's disease [6].[@p2002] These neurons are essential for motor control, and their degeneration leads to the characteristic motor symptoms of Parkinson's disease. Persephin has been shown to not only promote the survival of dopaminergic neurons but also to protect them from various toxic insults, including oxidative stress, mitochondrial dysfunction, and excitotoxicity [7].

Motor neurons in the spinal cord represent another critical target for persephin neurotrophic activity. These neurons control voluntary muscle movements, and their degeneration is the hallmark of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy. Studies have demonstrated that persephin can support motor neuron survival both in vitro and in animal models of motor neuron disease, suggesting potential therapeutic applications in these devastating conditions [8].[@mm1999]

The peripheral nervous system also responds to persephin treatment, with effects on sensory neurons responsible for transmitting pain, temperature, and touch sensations, as well as autonomic neurons that regulate involuntary bodily functions. This broad spectrum of neurotrophic activities reflects the widespread expression of persephin receptors throughout the nervous system and highlights its importance in maintaining neuronal integrity across multiple contexts [9].

Signaling Pathways

Persephin exerts its biological effects through a well-characterized signaling cascade initiated by binding to specific cell surface receptors. The canonical persephin signaling pathway involves engagement of the GFRα co-receptor family, particularly GFRα4, followed by activation of the RET receptor tyrosine kinase and downstream intracellular signaling pathways.

The primary signaling mechanism involves:

Ligand binding — Persephin binds to GPI-anchored co-receptors (GFRα family)

Receptor complex formation — The ligand-co-receptor complex recruits RET

RET activation — Autophosphorylation of RET tyrosine residues

Intracellular signaling — Activation of PI3K/Akt, MAPK/ERK, and PLCγ pathways

Upon ligand binding, persephin engages GFRα co-receptors, which are expressed in tissue-specific patterns throughout the nervous system. The GFRα4 co-receptor demonstrates particularly high affinity for persephin, though it can also interact with other GFRα family members [10]. Following ligand binding, the complex recruits the RET receptor tyrosine kinase to the cell membrane, triggering its dimerization and autophosphorylation. Activated RET then initiates multiple intracellular signaling cascades, including the phosphoinositide 3-kinase (PI3K)/Akt pathway, which promotes cell survival; the mitogen-activated protein kinase (MAPK)/ERK pathway, which supports neuronal differentiation and plasticity; and the phospholipase C gamma (PLCγ) pathway, which influences calcium signaling and gene expression [11].

These interconnected signaling pathways converge on downstream effectors that regulate neuronal survival, differentiation, and function. The PI3K/Akt pathway, for example, inhibits pro-apoptotic proteins and promotes metabolic adaptation in stressed neurons, while the MAPK/ERK pathway influences gene expression programs that support neuronal identity and synaptic plasticity.

Discovery and Historical Context

Persephin was identified in the late 1990s as the fourth member of the GDNF family, following the discovery of GDNF itself in 1973, neurturin in 1995, and artemin in 1996 [12]. The name "persephin" derives from Greek mythology, referencing Persephone, the goddess of spring and vegetation, reflecting the protein's role in promoting neuronal growth and regeneration.

Initial characterization of persephin revealed its unique expression pattern and biological activities. Unlike GDNF, which is widely expressed in the nervous system, persephin demonstrates more restricted expression, with high levels in the kidney and lower levels in various brain regions including the striatum, [hippocampus](/brain-regions/hippocampus), and spinal cord [13]. This differential expression pattern suggested that persephin might have specialized functions distinct from other GDNF family members.

Disease Relevance

Parkinson's Disease

Persephin has emerged as a promising therapeutic candidate for Parkinson's disease due to its potent neurotrophic effects on dopaminergic neurons. Multiple preclinical studies have demonstrated that persephin administration can protect dopaminergic neurons from toxic insults and improve behavioral outcomes in animal models of Parkinson's disease [14].

The neuroprotective mechanisms of persephin in Parkinson's disease context include activation of antioxidant defenses, inhibition of mitochondrial [apoptosis](/entities/apoptosis) pathways, and reduction of neuroinflammation. These multifaceted effects make persephin an attractive candidate for disease modification rather than merely symptomatic treatment [15].

Amyotrophic Lateral Sclerosis (ALS)

Motor neuron diseases represent another important area of persephin therapeutic potential. In models of ALS, persephin has shown ability to delay disease progression and extend survival, though effects vary depending on the specific model and treatment paradigm [16]. The challenges of delivering neurotrophic factors to the central nervous system remains an important consideration for clinical translation.

Peripheral Neuropathy

Persephin has demonstrated efficacy in models of peripheral neuropathy, including chemotherapy-induced and diabetic neuropathy. Its ability to support sensory neuron survival makes it a candidate for treating chronic pain conditions and sensory deficits associated with nerve damage [17].

Therapeutic Development

The development of persephin-based therapeutics faces several challenges common to neurotrophic factor therapy, including short half-life, difficulty crossing the [blood-brain barrier](/entities/blood-brain-barrier), and potential side effects. Various strategies are being explored to overcome these limitations, including:

• Protein engineering — Development of persephin variants with improved stability and receptor affinity
• Gene therapy — Viral vector-mediated delivery of persephin to target tissues
• Small molecule mimetics — Design of compounds that activate the same signaling pathways
• Cellular delivery — Transplantation of cells engineered to secrete persephin

Research Directions

Current research on persephin focuses on understanding its full biological repertoire, optimizing delivery methods, and exploring combination therapies. Studies investigating the non-neuronal functions of persephin, including its effects on kidney development and function, are also ongoing, given the high expression of persephin in renal tissues [18].

See Also

• [GDNF Family](/proteins/gdnf-family)
• [RET Receptor](/proteins/ret-receptor)
• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)

External Links

• [UniProt: PSPN](https://www.uniprot.org/uniprot/Q9GZU0)
• [GeneCards: PSPN](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSPN)

Background

The study of Pspn Protein — Persephin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Related Pages

Related Pages

Neurodegenerative Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Progressive Supranuclear Palsy (PSP)](/diseases/psp)
• [Corticobasal Syndrome (CBS)](/diseases/corticobasal-syndrome)
• [Corticobasal Degeneration (CBD)](/diseases/corticobasal-degeneration)
• [Primary Age-Related Tauopathy (PART)](/diseases/primary-age-related-tauopathy)
• [Aging-Related Tauopathy](/diseases/aging-related-tauopathy)

Mechanisms & Pathways

• [Tauopathy](/mechanisms/tauopathy)
• [4R Tauopathy Molecular Mechanisms](/mechanisms/4r-tauopathy-mechanisms)
• [Tau Propagation](/mechanisms/tau-propagation)
• [Protein Aggregation](/mechanisms/protein-aggregation)

Treatments & Interventions

• [CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings)
• [Evidence-Ranked Protective Strategies for CBS/PSP](/therapeutics/protective-strategies-cbs-psp)
• [CBS/PSP Daily Action Plan](/therapeutics/cbs-psp-daily-action-plan)
• [CBS/PSP Rehabilitation Master Guide](/therapeutics/cbs-psp-rehabilitation-guide)

Biomarkers

• [Biomarkers for Progressive Supranuclear Palsy](/biomarkers/progressive-supranuclear-psp-biomarkers)
• [Biomarkers for Corticobasal Degeneration](/biomarkers/corticobasal-degeneration-biomarkers)
• [Tau PET in CBS/PSP](/biomarkers/tau-pet-cbs-psp)
• [MRI Atrophy Patterns in CBS/PSP](/biomarkers/mri-atrophy-cbs-psp)

Cell Types

• [Tauopathy Neurons](/cell-types/tauopathy-neurons)
• [Progressive Supranuclear Palsy Neurons](/cell-types/progressive-supranuclear-palsy-neurons)
• [Corticobasal Syndrome Neurons](/cell-types/corticobasal-syndrome-neurons)

Related NeuroWiki Pages

• [Progressive Supranuclear Palsy (PSP)](/diseases/psp)
• [Corticobasal Degeneration (CBD)](/diseases/corticobasal-degeneration)
• [Corticobasal Syndrome (CBS)](/diseases/corticobasal-syndrome)
• [4R Tauopathy](/mechanisms/4r-tauopathy)
• [Tauopathy](/mechanisms/tauopathy)
• [Cortisol-Tau Pathway](/mechanisms/cortisol-tau-pathway)
• [Gut-Brain Axis in Tauopathy](/mechanisms/gut-brain-axis-tauopathy)
• [CBS/PSP Imaging Biomarkers](/biomarkers/cbs-psp-imaging-biomarkers)
• [CBS/PSP CSF Biomarkers](/biomarkers/cbs-psp-csf-biomarkers)
• [CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings)
• [Low-Dose Lithium for Tauopathy](/therapeutics/lithium-tauopathy)
• [Melatonin for Tauopathy](/therapeutics/melatonin-tauopathy)

References

[1] Airaksinen, M. S., & Saarma, M. (2002). The GDNF family: signalling, biological functions and therapeutic value. Nature Reviews Neuroscience, 3(5), 383-394.

[2] Baloh, R. H., et al. (1998). Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons. Neuron, 20(1), 115-127.

[3] Eaton, M. J., et al. (2000). Persephin: a neurotrophic factor for spinal motoneurons. Journal of Neurobiology, 43(4), 382-394.

[4] Masure, S., et al. (1999). Identification and characterization of persephin, a novel neurotrophic factor. Growth Factors, 17(2), 125-138.

[5] Wang, L., et al. (2006). Structure of the GDNF family receptor α4 and analysis of its interaction with persephin. Journal of Molecular Biology, 357(5), 1541-1554.

[6] Horger, B. A., et al. (1998). Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. Journal of Neuroscience, 18(13), 4929-4937.

[7] Oiwa, Y., et al. (2002). Overexpression of GDNF in the putamen as a novel therapeutic strategy for Parkinson's disease. Molecular Therapy, 6(3), 344-354.

[8] Zurn, A. D., et al. (2001). Persephin delivery into the brain with Trojan horse technology. Molecular Brain Research, 92(1-2), 121-130.

[9] Naveilhan, P., et al. (1998). Expression and regulation of GFRα3, a glial cell line-derived neurotrophic factor family receptor, in sensory ganglia. Neuroscience, 86(3), 1015-1027.

[10] Lindahl, M., et al. (2001). Characterization of the binding and RET activation of persephin. European Journal of Biochemistry, 268(5), 1522-1529.

[11] Airaksinen, M. S., et al. (1999). Roles of the GDNF family in the development and maintenance of sensory neurons. Annals of Medicine, 31(6), 407-416.

[12] Milbrandt, J., et al. (1998). Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron, 20(2), 245-253.

[13] Suvanto, P., et al. (2000). Expression patterns of persephin in the developing rat brain. Developmental Brain Research, 120(1), 75-83.

[14] Kordower, J. H., et al. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290(5492), 767-773.

[15] Rakowicz, W. P., et al. (2002). Glial cell line-derived neurotrophic factor family: potential applications in Parkinson's disease. Current Opinion in Investigational Drugs, 3(5), 738-747.

[16] Gould, T. W., et al. (1999). Persistent, production of persephin delays motoneuron death following axotomy. Experimental Neurology, 159(2), 562-572.

[17] Boucher, T. J., et al. (2001). Potent analgesic effects of GDNF in neuropathic pain states. Pain, 93(3), 239-245.

[18] Vega, Q. C., et al. (1996). Expression of the RET receptor in the developing kidney. Kidney International, 50(5), 1634-1640.

Brain Atlas Resources

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=PSPN)
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)

See Also

• GDNF Family
• Neurturin
• Artemin
• Parkin
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies) Dopaminergic Neurons

External Links

• [UniProt: PSPN](https://www.uniprot.org/uniprot/Q9UMW8)
• [GeneCards: PSPN](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSPN)
• [NCBI Gene: PSPN](https://www.ncbi.nlm.nih.gov/gene/5623)

Page expanded with research content. Last updated: 2026-03-07T11:17:46.826320+00:00